October 21, 2021 – October 21, 2021 – Radiant received a seed investment from FACIT’s Compass Rose Oncology Fund.
Category: Uncategorized
FACIT Features: Replica Analytics, Ottawa-based start-up in health data artificial intelligence
October 13, 2021 – October 13, 2021 – Having recently announced several collaborations following the closing of a financing round with Nina Capital, Replica has significant momentum behind it.
FACIT Features: Turnstone Biologics completes oversubscribed $80M USD Series D Financing
July 21, 2021 – July 21, 2021 – The start-up seeded by FACIT in collaboration with several Ontario research institutes continues to deepen its roots in Canada and grow on both sides of the border.
FACIT Features: Notch Therapeutics Closes $85M USD Series A for Renewable Stem Cell-Derived Cancer Immunotherapies
February 10, 2021 – February 10, 2021 – The financing is one of the largest Series A financing round in Canadian biotech history, notably at a time of heightened interest by Ontario in commercializing homegrown intellectual property.
FACIT Features: Triphase Accelerator reports positive interim results of lead compound in Phase 1 Clinical Trial for Lymphoma
December 8, 2020 – December 8, 2020 – FACIT congratulates Triphase Accelerator on interim results from its ongoing Phase 1 multi-center, open-label monotherapy study of TRPH-222.
FACIT Features: DNAstack to lead and develop COVID Cloud for Canada’s Digital Technology Supercluster
December 1, 2020 – December 1, 2020 – FACIT is pleased to accept the invitation to join the national consortium as Lead Commercialization Advisor.
FACIT Features: Portfolio company KA Imaging secures FDA approval for portable dual-energy x-ray detector
September 17, 2020 – September 17, 2020 – Since FACIT’s early seed investment in KA Imaging, the company has greatly expanded its IP portfolio, as well as the number of highly skilled jobs it has brought to Ontario.
FACIT congratulates Fusion Pharma on its Initial Public Offering
June 26, 2020 – June 26, 2020 – FACIT congratulates Hamilton-based Fusion Pharma (NASDAQ: FUSN) on its initial public offering (IPO) with shares of the company beginning to trade on the Nasdaq Global Market exchange today.
Read More from FACIT congratulates Fusion Pharma on its Initial Public Offering
FACIT Features: OICR leads international team to generate world’s most comprehensive cancer genome map
February 6, 2020 – February 6, 2020 – The output from this global study vastly improves the fundamental understanding of cancer and will provide guidance and new directions for its diagnosis and treatment
FACIT Announces Artificial Intelligence pitch as Winner of 2020 Falcons’ Fortunes on World Cancer Day
February 5, 2020 – February 5, 2020 – The winning pitch was delivered by Mr. Meir Dick of Bridge7 Oncology. This local start-up is scaling clinical expertise with AI to automate and improve the efficiency, consistency and quality of delivering cancer care.